Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Open Access
- 1 July 2009
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 84 (7), 632-638
- https://doi.org/10.1016/s0025-6196(11)60752-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- More on Atypical Fractures of the Femoral DiaphysisThe New England Journal of Medicine, 2008
- Vitamin D status and response to treatment in post-menopausal osteoporosisOsteoporosis International, 2008
- Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control studyBMJ, 2008
- Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesLeukemia & Lymphoma, 2008
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Alendronate and Atrial FibrillationThe New England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- Pharmacokinetics/Pharmacodynamics of BisphosphonatesClinical Pharmacokinetics, 2005
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled StudyMayo Clinic Proceedings, 2002